Event Type
Disclosure
Voluntary
Variant
8-K
and Exhibits 99.1 and 99.2 attached hereto shall not be deemed an admission as to the materiality of any information in this Current Report on Form 8-K that is
. Financial Statements and Exhibits (d) Exhibits: Exhibit No. Description 99.1 Press Release, dated September 2, 2025. 99.2 Pelthos Therapeutics Inc. Q3 2025 Pr